What is the best treatment for a patient with fungal infections on the chest, skin folds, and groin, potentially complicated by diabetes or immunosuppression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cutaneous Candidiasis (Yeast Infection) on Chest, Skin Folds, and Groin

Apply topical azole antifungals (clotrimazole, miconazole, ketoconazole, oxiconazole, or econazole) twice daily to all affected areas for 7-14 days, continuing for at least one week after clinical resolution, and ensure the infected areas remain dry throughout treatment. 1

First-Line Topical Treatment

  • Topical azoles are the primary treatment for candidal skin infections in intertriginous areas (skin folds), with cure rates of 80-85% 1
  • Apply twice daily for a minimum of 7-14 days, extending treatment for at least one week after symptoms resolve 1
  • Nystatin (a polyene antifungal) is equally effective as an alternative, with complete cure rates of 73-100% 2, 3
  • Both drug classes work well for candidal infections in obese and diabetic patients 1

Critical Adjunctive Measure

  • Keeping the infected area dry is essential for successful treatment and is as important as the antifungal medication itself 1, 2
  • Failure to maintain dryness, particularly in skin fold areas (intertrigo), is a common pitfall that leads to treatment failure 1
  • This is especially important in the groin and under skin folds where moisture accumulates 1

Special Considerations for Diabetic or Immunosuppressed Patients

  • Optimize glycemic control in diabetic patients to prevent recurrence, as high blood glucose promotes yeast growth and impairs immune responses 1, 4
  • Poorly controlled diabetes increases risk of both initial infection and recurrence 4, 5
  • Diabetic patients may require higher doses (up to 800 mg/day of fluconazole) in severe or recurrent cases 5
  • Consider that Candida glabrata is more common in type 2 diabetes and is less susceptible to conventional antifungal treatment 4

When to Consider Systemic Therapy

  • Oral fluconazole 100-200 mg daily may be considered for extensive disease or when topical therapy fails 3
  • Systemic therapy is generally reserved for widespread infections, immunocompromised patients, or treatment failures 1, 2
  • For mucocutaneous candidiasis, fluconazole 100-200 mg/day for 7-14 days is effective 3

Treatment Duration and Monitoring

  • Continue treatment for at least one week after all visible signs have cleared to prevent recurrence 1
  • Most uncomplicated cases resolve within 7-14 days with appropriate topical therapy 3
  • Follow-up test-of-cure is generally unnecessary given high efficacy rates 4

Common Pitfalls to Avoid

  • Do not use topical therapy alone for nail involvement (onychomycosis), which requires oral itraconazole 2
  • Avoid stopping treatment when skin appears healed; complete the full course to prevent recurrence 1
  • Do not neglect moisture control measures, as this is the most common reason for treatment failure in skin fold infections 1, 2
  • Address underlying risk factors including diabetes control, antibiotic use, corticosteroid use, and immunosuppression 4

References

Guideline

Treatment for Skin Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Treatment of Fungal Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.